MARTA
SECO CERVERA
INVEST CONT VALi+d
CARLOS
ROMA MATEO
TITULAR DE UNIVERSIDAD
CARLOS ROMA MATEO-rekin lankidetzan egindako argitalpenak (8)
2020
-
Thioredoxin and glutaredoxin systems as potential targets for the development of new treatments in Friedreich’s ataxia
Antioxidants, Vol. 9, Núm. 12, pp. 1-25
2019
-
Epigenetic biomarkers for disease diagnosis
Prognostic Epigenetics (Elsevier), pp. 21-44
2018
-
Oxidative stress and the epigenetics of cell senescence: Insights from progeroid syndromes
Current Pharmaceutical Design, Vol. 24, Núm. 40, pp. 4755-4770
2017
-
Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory
Critical Reviews in Clinical Laboratory Sciences, Vol. 54, Núm. 7-8, pp. 529-550
2016
-
Circulating Histones and Nucleosomes as Biomarkers in Sepsis and Septic Shock
Epigenetic Biomarkers and Diagnostics (Elsevier Inc.), pp. 497-517
-
Circulating histones and nucleosomes as biomarkers in sepsis and septic shock
Epigenetic biomarkers and diagnostics (Amsterdam [etc.]: Elsevier, 2016), pp. 498-519
2015
-
Increased Oxidative Stress and Impaired Antioxidant Response in Lafora Disease
Molecular Neurobiology, Vol. 51, Núm. 3, pp. 932-946
2013
-
Lafora disease fibroblasts exemplify the molecular interdependence between thioredoxin 1 and the proteasome in mammalian cells
Free Radical Biology and Medicine, Vol. 65, pp. 347-359